Joshi Pallavi, Duong Karen T, Trevisan Louis A, Wilkins Kirsten M
Department of Psychiatry, Yale School of Medicine, 300 George Street, New Haven, CT 06511 USA.
Department of Psychiatry, University of Texas Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.
Curr Geriatr Rep. 2021;10(3):82-90. doi: 10.1007/s13670-021-00359-5. Epub 2021 Jul 24.
The prevalence of alcohol use disorder (AUD) among older adults in the United States is rising, but remains underdiagnosed, underreported, and inadequately managed. This review highlights the medical, social, and cultural factors of AUD in older adults and provides guidelines for its screening, evaluation, and management.
The COVID-19 pandemic has created additional challenges and barriers to care, as older adults may have disproportionate worsening of anxiety, depression, and substance use resulting from increased isolation related to physical distancing and shelter-in-place guidelines.
All older adults should be routinely screened for AUD with standardized screening tools. If a patient's screening results are positive, a clinician should conduct a brief assessment, which may be supplemented by laboratory tests. Most older adults at risk for alcohol misuse do not need specialized SUD treatment, but most can benefit from Screening, Brief Intervention, and Referral to Treatment (SBIRT) to prevent substance misuse before it occurs. Medications for the treatment of AUD in older adults include naltrexone, acamprosate, disulfiram, gabapentin and topiramate. Psychosocial treatments, including mutual help groups, are equally important.
美国老年人中酒精使用障碍(AUD)的患病率正在上升,但仍存在诊断不足、报告不足和管理不当的问题。本综述重点介绍了老年人AUD的医学、社会和文化因素,并为其筛查、评估和管理提供指导方针。
COVID-19大流行给护理带来了额外的挑战和障碍,因为老年人可能因与物理距离和就地避难指南相关的隔离增加而导致焦虑、抑郁和物质使用情况不成比例地恶化。
所有老年人都应使用标准化筛查工具进行AUD常规筛查。如果患者的筛查结果呈阳性,临床医生应进行简短评估,并可辅以实验室检查。大多数有酒精滥用风险的老年人不需要专门的物质使用障碍治疗,但大多数人可以从筛查、简短干预和转介治疗(SBIRT)中受益,以在物质滥用发生之前进行预防。用于治疗老年人AUD的药物包括纳曲酮、阿坎酸、双硫仑、加巴喷丁和托吡酯。心理社会治疗,包括互助小组,同样重要。